Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Inogen ( (INGN) ) is now available.
On January 25, 2025, Inogen announced a strategic collaboration with Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. to expand their product portfolio and innovation pipeline, and to enter the Chinese market. This partnership involves distribution agreements and a $27.2 million equity investment from Yuwell, enhancing Inogen’s market positioning and financial stability.
More about Inogen
Inogen, Inc. is a global medical technology company specializing in innovative respiratory products for homecare settings. The company develops, manufactures, and markets respiratory therapy devices to aid patients with chronic respiratory conditions, collaborating with patients, prescribers, and distributors to enhance accessibility.
YTD Price Performance: 24.48%
Average Trading Volume: 200,363
Technical Sentiment Consensus Rating: Hold
Current Market Cap: $272.5M
For detailed information about INGN stock, go to TipRanks’ Stock Analysis page.
